ClinicalTrials.govpublic full text
A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer
colorectal cancer, phase 1, dose escalation, histologically, confirmed, malignancy, metastatic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 812099
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.